Do you have solid tumor of the lung or esophagus? Have the standard treatments for your condition been ineffective or not tolerable? If so, you may be eligible to participate in an early phase research study of the investigational drug YL201 as a possible treatment for advanced solid tumors.

The purpose of this research is to see if an experimental vaccine, which is created from your tumor tissue and dendritic cells isolated from your blood, can be an effective therapy when given after your standard treatment of surgery, chemotherapy, and radiation.

The purpose of this study is to look at the effectiveness of giving cemiplimab and XL092 before and after surgery for Anaplastic Thyroid Cancer.

By doing this study, we hope to learn if the combination of belantamab mafodotin, carfilzomib, pomalidomide, and dexamethasone is effective and safe when given to persons with multiple myeloma that has gotten worse and is not responding to standard drugs that are used for treating multiple myeloma, including chimeric antigen receptor T-cell therapy.

Have you been diagnosed with metastatic non-small cell lung cancer? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of pembrolizumab to the investigational drug, ivonescimab in treating this condition.

Do you have Relapsed and Refractory CLL, SLL, or Select Low-grade Lymphomas? Have you received at least 2 or more therapies that have included BTKi and venetoclax? If so, you may be able to take part in a study on a drug called ZE50-0134 to treat patients with these conditions. We will also check if various doses of this medicine are safe for treatment.

Have you been diagnosed with metastatic cutaneous melanoma? Have you previously been treated for your melanoma, or maybe it can't be removed? If so, you might be eligible to take part in a study to compare how well a new drug, IMA203, can treat your cancer compared to your physician's choice of treatment.

In this study, we are looking at a new ultrasound method called contrast-enhanced super-resolution (CESR) imaging. We want to help doctors better understand a patient's risk of cancer.

Have you been diagnosed with CLL or other forms of indolent lymphoma? If so this could be a good study for you to paticipate in. One of the primary goals of this study is To investigate the feasibility of the referral and engagement process in fatigue mitigation intervention for cancer-related fatigue among adults with CLL or other forms of indolent lymphoma.

We want to learn how couples dealing with prostate cancer handle food preparation and eating together.